These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34956895)

  • 1. The ncRNA-Mediated Overexpression of Ferroptosis-Related Gene EMC2 Correlates With Poor Prognosis and Tumor Immune Infiltration in Breast Cancer.
    Liu X; Yang P; Han L; Zhou Q; Qu Q; Shi X
    Front Oncol; 2021; 11():777037. PubMed ID: 34956895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
    Sun Q; Liu X; Peng Q; Hu L; Jiang X
    J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
    Fu H; Li K; Wang S; Li Y
    Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ferroptosis-related genes for overall survival prediction in breast cancer.
    Jin LY; Gu YL; Zhu Q; Li XH; Jiang GQ
    J Clin Lab Anal; 2021 Dec; 35(12):e24094. PubMed ID: 34741349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 7. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
    Lou W; Wang W; Chen J; Wang S; Huang Y
    Mol Ther Nucleic Acids; 2021 Jun; 24():845-855. PubMed ID: 34026328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs-based high KIF26B expression correlates with poor prognosis and tumor immune infiltration in colon cancer.
    Liu Z; Zhou X; Chen B; Wu Z; Zhang C; Gu C; Li J; Yang X
    Cell Cycle; 2023; 22(14-16):1726-1742. PubMed ID: 37436127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
    Mao G; Shan C; Li W; Liang B; Ma L; Zhang S
    Int J Gen Med; 2022; 15():2607-2620. PubMed ID: 35282644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential upstream lncRNA-miRNA-mRNA regulatory network of the ferroptosis-related gene
    Xu F; Ji S; Yang L; Li Y; Shen P
    Transl Androl Urol; 2023 Jan; 12(1):33-57. PubMed ID: 36760866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer.
    He Z; Zhou Z; Wang F; Gai L; Huang Y; Zhong X; Li J; Zuo L; Zhang N; Ni S
    Ann Transl Med; 2022 Aug; 10(15):833. PubMed ID: 36035010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma.
    Fang W; Gan Y; Zhang L; Xiong J
    Front Oncol; 2022; 12():853026. PubMed ID: 35574298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer.
    Chen R; Wang X; Fu J; Liang M; Xia T
    Front Genet; 2022; 13():956869. PubMed ID: 36159964
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 18. ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma.
    Shu C; Liu L; Chen X; Xue J; Fei J; Wang J; Yang X; Peng Q; Yuan H
    Ann Transl Med; 2023 Jan; 11(1):10. PubMed ID: 36760244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer.
    Lian W; Yang P; Li L; Chen D; Wang C
    Front Med (Lausanne); 2023; 10():1194046. PubMed ID: 37275369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NcRNA-mediated upregulation of CAMK2N1 is associated with poor prognosis and tumor immune infiltration of gastric cancer.
    Peng K; Ren X; Ren Q
    Front Genet; 2022; 13():888672. PubMed ID: 36092901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.